These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20020360)

  • 1. Phase-II metabolism of androgens and its relevance for doping control analysis.
    Kuuranne T
    Handb Exp Pharmacol; 2010; (195):65-75. PubMed ID: 20020360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse.
    Schulze JJ; Rane A; Ekström L
    Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):731-44. PubMed ID: 19442030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forensic relevance of glucuronidation in phase-II-metabolism of alcohols and drugs.
    Kaeferstein H
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S22-6. PubMed ID: 19269237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen abuse in sports.
    Handelsman DJ; Heather A
    Asian J Androl; 2008 May; 10(3):403-15. PubMed ID: 18385902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs).
    Rydevik A; Thevis M; Krug O; Bondesson U; Hedeland M
    Xenobiotica; 2013 May; 43(5):409-20. PubMed ID: 23153056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison.
    Hintikka L; Kuuranne T; Leinonen A; Thevis M; Schänzer W; Halket J; Cowan D; Grosse J; Hemmersbach P; Nielen MW; Kostiainen R
    J Mass Spectrom; 2008 Jul; 43(7):965-73. PubMed ID: 18563858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry.
    Thevis M; Thomas A; Delahaut P; Bosseloir A; Schänzer W
    Anal Chem; 2006 Mar; 78(6):1897-903. PubMed ID: 16536426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Masking and manipulation.
    Ventura R; Segura J
    Handb Exp Pharmacol; 2010; (195):327-54. PubMed ID: 20020372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
    Badoud F; Grata E; Perrenoud L; Avois L; Saugy M; Rudaz S; Veuthey JL
    J Chromatogr A; 2009 May; 1216(20):4423-33. PubMed ID: 19342059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of hydroxylated mesocarb metabolites for doping control.
    Vahermo M; Suominen T; Leinonen A; Yli-Kauhaluoma J
    Arch Pharm (Weinheim); 2009 Apr; 342(4):201-9. PubMed ID: 19340833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites.
    Kohler M; Parr MK; Opfermann G; Thevis M; Schlörer N; Marner FJ; Schänzer W
    Steroids; 2007 Mar; 72(3):278-86. PubMed ID: 17207827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6alpha-Methylandrostenedione: gas chromatographic mass spectrometric detection in doping control.
    Parr MK; Kazlauskas R; Schlörer N; Opfermann G; Piper T; Schulze G; Schänzer W
    Rapid Commun Mass Spectrom; 2008; 22(3):321-9. PubMed ID: 18181236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases.
    Kuuranne T; Kurkela M; Thevis M; Schänzer W; Finel M; Kostiainen R
    Drug Metab Dispos; 2003 Sep; 31(9):1117-24. PubMed ID: 12920167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of a liquid-phase microextraction sample clean-up and liquid chromatographic/mass spectrometric screening method for selected anabolic steroid glucuronides in biological samples.
    Kuuranne T; Kotiaho T; Pedersen-Bjergaard S; Einar Rasmussen K; Leinonen A; Westwood S; Kostiainen R
    J Mass Spectrom; 2003 Jan; 38(1):16-26. PubMed ID: 12526002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.
    Handelsman DJ; Goebel C; Idan A; Jimenez M; Trout G; Kazlauskas R
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):417-28. PubMed ID: 19170708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methodologies used to screen for doping agents].
    Audran M
    Ann Pharm Fr; 2002 Sep; 60(5):310-3. PubMed ID: 12378139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human urinary excretion of sulfamate and glucuronide conjugates of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MelQx).
    Stillwell WG; Turesky RJ; Gross GA; Skipper PL; Tannenbaum SR
    Cancer Epidemiol Biomarkers Prev; 1994; 3(5):399-405. PubMed ID: 7920207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of androst-4-ene-3,6,17-trione (6-OXO) and its metabolites in urine by gas chromatography-mass spectrometry in relation to doping analysis.
    Van Thuyne W; Van Eenoo P; Mikulcíková P; Deventer K; Delbeke FT
    Biomed Chromatogr; 2005 Nov; 19(9):689-95. PubMed ID: 15828056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite.
    Thevis M; Geyer H; Mareck U; Flenker U; Schänzer W
    Ther Drug Monit; 2007 Apr; 29(2):236-47. PubMed ID: 17417080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.